CS logo
small CS logo
Unita Sperimentazioni Cliniche Istituto per lo

Napoli, Italy

About Unita Sperimentazioni Cliniche Istituto per lo


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Unita Sperimentazioni Cliniche Istituto per lo


During the past decade, Unita Sperimentazioni Cliniche Istituto per lo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Unita Sperimentazioni Cliniche Istituto per lo" #1 collaborator was "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials as a collaborator, "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "Central and Eastern European Oncology Group" with 1 trials as a collaborator, "Chinese Thoracic Oncology Group" with 1 trials as a collaborator and "Dutch Society of Physicians for Pulmonology and Tuberculosis" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

Clinical Trials Conditions at Unita Sperimentazioni Cliniche Istituto per lo


According to Clinical.Site data, the most researched conditions in "Unita Sperimentazioni Cliniche Istituto per lo" are "Lung Cancer" (1 trials), "Mesothelioma" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Unita Sperimentazioni Cliniche Istituto per lo" in a lesser frequency.

Clinical Trials Intervention Types at Unita Sperimentazioni Cliniche Istituto per lo


Most popular intervention types in "Unita Sperimentazioni Cliniche Istituto per lo" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Cisplatin" (1 trials), "MEDI4736" (1 trials), "PF-00299804" (1 trials) and "Pembrolizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Unita Sperimentazioni Cliniche Istituto per lo


The vast majority of trials in "Unita Sperimentazioni Cliniche Istituto per lo" are 3 trials for "All" genders.

Clinical Trials Status at Unita Sperimentazioni Cliniche Istituto per lo


Currently, there are NaN active trials in "Unita Sperimentazioni Cliniche Istituto per lo". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Unita Sperimentazioni Cliniche Istituto per lo, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Unita Sperimentazioni Cliniche Istituto per lo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".